VCG
EXAS

Vantage Consulting Group’s Exact Sciences EXAS Stock Holding History

Vantage Consulting Group’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-6
Closed -$1K – 576
2020
Q4 		$1K Buy
+6
New +$726 ﹤0.01% 1744

Other funds holding EXAS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Vantage Consulting Group's EXAS Position: Q1 2021 in Review

Vantage Consulting Group sold out of Exact Sciences (EXAS) in Q1 2021, closing a stake of 6 shares — an estimated $1K sold.

Vantage Consulting Group first reported a position in EXAS in Q4 2020 and held it in 1 quarter. The position peaked at $1K in Q4 2020. 646 funds tracked by Wall St. Rank hold EXAS as of Q1 2021.

  • Vantage Consulting Group reported no remaining Exact Sciences position as of Q1 2021 after selling out during the quarter.
  • Vantage Consulting Group sold 6 Exact Sciences shares in Q1 2021, an estimated $1K.
  • Vantage Consulting Group first reported a position in Exact Sciences in Q4 2020 and held it in 1 quarter.
  • Vantage Consulting Group's Exact Sciences position peaked at $1K in Q4 2020.
  • 646 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2021.

Based on Vantage Consulting Group's 13F filing for Q1 2021, filed 14 May 2021.